I grew up between two worlds. My two older sisters followed my parents into medicine. I chose computer science - at a time when most people assumed the two fields had little to say to each other.

I was not so sure.

At avisé labs, that question became our starting point. We build AI-powered software for health, pharma and life sciences designed to extend decision-making. Not to replace it. Not to abstract it away. But to strengthen it.

Much of today’s medical AI is built as if medicine were primarily a data problem. It is not. It is a judgment problem. Data matters. Algorithms matter. But without context, without responsibility, and without integration into real clinical environments, even the most sophisticated systems fail to deliver meaningful outcomes.

We saw this early when we started in dermatology. It is one of the most visually complex fields in medicine. Well suited for machine learning, but also deeply dependent on clinical intuition. A dermatologist examining a lesion brings years of experience into a single moment of judgment. The question is not whether a model can match that judgment. The question is how to build systems that augment it, systems that learn from vast amounts of data while remaining accountable to the clinician who ultimately carries responsibility for the patient.

Since then we have expanded into neurology, sleep medicine, dentistry and intensive care medicine. The fields are different. The principle is the same: technology should serve the patient and clinician.
What we have learned over seven years of building medical software is that the hardest problems are rarely technical. The algorithms improve. The compute gets cheaper. The data accumulates. What does not automatically improve is the judgment about how these tools should be used, who they should serve, and what values should be encoded in their recommendations. Those questions require human decisions and they require the right people in the room when those decisions are made.

This is why the question of infrastructure matters as much to us as the question of algorithms. Modern medical AI does not exist in isolation. It runs on cloud architectures, depends on data pipelines and operates within regulatory frameworks that are still catching up with the pace of change. At avisé labs, building cloud-based software solutions for the medical and life sciences sector means navigating this landscape every day, ensuring that the systems we develop are not only technically robust but compliant, auditable and built to the standards that regulators and healthcare institutions rightly demand. The infrastructure is not a background concern. It is where the real decisions about how AI operates in medicine are made.

That is why avisé labs works the way it does. We build in close collaboration with medical professionals, not alongside them at a distance. We work with medtech companies, research institutions and pharmaceutical companies across the globe, because we believe the best medical AI emerges from genuine interdisciplinary partnership. A system built by software engineers alone, however talented, will reflect the priorities of software engineers. A system built together with the people who actually use it and the patients who depend on it, reflects something closer to the truth of what medicine needs.

I am proud of what we have built. I am more proud of how we have built it. And I am proud to work alongside a talented and dedicated team. None of our results would have been possible without the people who show up every day.

The years ahead will be transformative for medicine in ways that are difficult to fully anticipate. AI will accelerate drug discovery, improve diagnostics for underserved populations and extend precision medicine to patients currently excluded from its benefits. I believe this genuinely and work towards it every day. But I also believe that this transformation will only serve patients well if the people building these systems take seriously their responsibility to the values that European healthcare has always embodied: equity, access and care for the vulnerable.

That responsibility is not a constraint on ambition. It is the foundation of it.

One more word about today‘s complex world we live in: I am endlessly grateful that life has given me the opportunity to do the kind of work I do, and that avisé takes me around the world to collaborate with such generous and brilliant partners. Growing up in a family spread across cultures and across the globe, I always believed that the most important things, in life and in business, happen at the point where different perspectives meet. What I did not fully anticipate was how much I would continue to learn: from partners in Korea, from colleagues across Europe, from partners in Silicon Valley, from clinicians whose daily reality is nothing like mine. Every one of those encounters has made me think differently. That is not a soft benefit. It is the source of our best work.

What I have come to believe, through all of it, is that the most resilient and innovative companies are not those that retreat into comfortable certainties. They are the ones that build cultures of genuine openness, cultures they could not find ready-made anywhere else, so they constructed them deliberately. At avisé labs that means seeking out partners and colleagues who challenge us, clients who push us beyond what we already know, and collaborators who bring perspectives that our own background cannot provide.

In a world that sometimes seems to be pulling inward, toward insularity, toward short-term thinking, toward the illusion that complexity can be solved by simplification, I believe companies have a responsibility to demonstrate a different way. Not only through statements, but through how they work every day. Building across borders, across disciplines and across cultures is not just good ethics. In medicine especially, where the problems are universal and the stakes are human, it is the only approach that is equal to the challenge.

That is the company avisé labs is trying to be.
And that is the invitation we extend to everyone we work with.



Sincerely,

Marius Khan

Co-Founder & CEO, avisé labs GmbH